Drug intelligence / Profile preview

bupivacaine + lidocaine + morphine + epinephrine + ketorolac

Development stage
Unknown
Lead developer
Northern Orthopaedic Division
Modality
Small Molecules
Administration
Epidural, Intravenous, Local Infiltration
01

Overview

This multimodal perioperative pain management protocol was developed and evaluated by the Northern Orthopaedic Division in Denmark for patients undergoing circumferential lumbar fusion surgery. The regimen, referred to as "local anaesthesia" in the context of the clinical trial NCT00463112, consists of a comprehensive combination of analgesics administered through multiple routes. It includes preemptive and postoperative local infiltration with bupivacaine, preemptive epidural analgesia using lidocaine and morphine, followed by a 72-hour continuous postoperative epidural infusion of bupivacaine, morphine, and epinephrine. Additionally, intravenous ketorolac is administered after wound closure. This integrated approach is designed to facilitate "fast-track" recovery by optimizing pain control, reducing the need for standard postoperative opioids, and enhancing early mobilization and rehabilitation.

Other names
Multimodal Perioperative Pain Management (Northern Orthopaedic Division)Fast-track rehabilitation program (Northern Orthopaedic Division)
02

Targets

ADRB1 (β1)PGHS-1 (Prostaglandin G/H Synthase 1)MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRB2 (β2)ADRA1A (α1A)NaV (Voltage-gated sodium channels)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on bupivacaine + lidocaine + morphine + epinephrine + ketorolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + lidocaine + morphine + epinephrine + ketorolac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call